People's immune systems deteriorate as they age, making cancer therapies that rely on immune cells difficult to implement. In a new study, researchers from the University of Lausanne (UNIL), the Lausanne University Hospital (CHUV), the Geneva University Hospitals (HUG), and the Ecole Polytec
Researchers at Emory University's Winship Cancer Institute discovered a new form of immune cell known as the stem-like CD4 T cell, which plays an important role in anti-tumor immunity. The pre-clinical findings, published in Nature, indicate the potential for activating these cells to combat
According to a preclinical study conducted by Weill Cornell Medicine researchers, it may soon be feasible to detect whether individuals with hepatocellular carcinoma, a kind of liver cancer, may benefit from immunotherapy.
Columbia researchers developed probiotic bacteria that train the immune system to eliminate cancer cells, paving the way for a new class of cancer vaccinations that take advantage of bacteria's innate tumour-targeting abilities. These microbial cancer vaccines can be tailored to each person'
Under this agreement, Sun Pharma will hold exclusive global rights to commercialise Fibromun, while Philogen will continue conducting pivotal clinical trials, pursue marketing authorisation from regulatory bodies, and manufacture the product.
Researchers have discovered a possible target for cancer immunotherapy. The research, directed by Professor Massimiliano Mazzone, discovered that the CDA gene is one of the most elevated metabolic genes in immunotherapy-resistant cancer. Inhibiting this gene through pharmacological or geneti
Developing nerve cells outside the brain is where neuroblastoma, a common childhood disease, starts. Over 40 per cent of patients with high-risk neuroblastoma currently do not survive, despite the fact that patient's chances of survival have increased with more aggressive treatments.
Liver inflammation, a typical side effect of malignancies elsewhere in the body, has long been associated with poor cancer outcomes and, more recently, with poor response to immunotherapy. A team of researchers from the University of Pennsylvania's Abramson Cancer Centre and Perelman School
Researcher Paul Dent of Virginia Commonwealth University's Department of Biochemistry and Molecular Biology found that tumours that have metastasized to distant locations, such as the brain, are most often impossible to treat and cure, despite recent successes in some tumour types such as NS
Researchers at the University of Michigan Health Rogel Cancer Centre discovered a mechanism connected to serious gastrointestinal problems following immune-based cancer treatment.
A mechanism linked to severe gastrointestinal issues during immune-based cancer treatment has been discovered by researchers at the University of Michigan Health Rogel Cancer Centre.
They also found a way to deliver immunotherapy's cancer-killing impact without the unwelcome side effect. Th